Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors

FDA Approves Autolus’s CAR-T Therapy Aucatzyl for Relapsed or Refractory B-ALL in Adults

Biosimilars: Expanding Access to Precision Medicine through Affordable Biologic Therapies

IDEAYA Biosciences Secures Exclusive Worldwide License for Biocytogen’s BsADC Program IDE034 for Solid Tumor Treatment

Seer and Thermo Fisher Scientific Announce Strategic Collaboration to Advance Proteomics with Integrated Platform Solution

SystImmune Secures FDA Clearance for IND Application of Novel ADC Therapy BL-M17D1 for Advanced Solid Tumors

Medicare Expands Coverage for Adaptive Biotechnologies' clonoSEQ® MRD Test to Include Mantle Cell Lymphoma

Illumina and PHASE Partner to Advance Oncology Testing in the Greater Bay Area, Supporting the "Healthy China" Initiative

MGI Partners with Human Cell Atlas to Advance Global Human Cell Mapping

NHS Wales and Illumina Expand Partnership to Advance Genomic Cancer Detection and Personalized Medicine

Unlocking Genomic Potential for Rare Cancers: Cancer52 and Genomics England’s Collaborative Approach

Tempus AI Launches Immune Profile Score to Enhance Precision in Immunotherapy for Advanced Cancer Patients

Key Resources and Organizations for Precision Medicine Guidelines

MedGenome Strengthens Leadership Team to Drive North American Expansion in Precision Medicine

NCCN Expands Clinical Practice Guidelines for High-Risk Genetic Cancer Assessment

Home
/
update
/
details

UAE: Genetic Testing Required for Citizens Marrying in Abu Dhabi Starting October 1

NextEdge Admin

13 Sep 2024

1 min 49 sec

Starting October 1, citizens in Abu Dhabi will be required to undergo genetic testing as part of the premarital screening program, according to the Department of Health (DoH). This service will be available at 22 primary care centers across Abu Dhabi, Al Dhafra, and Al Ain, with results provided within 14 days. The genetic screening tests for 570 genes linked to over 840 autosomal recessive genetic disorders, helping couples identify if they carry mutations that could potentially affect their future children.

Dr. Asma Al Mannaei, Executive Director of the Research and Innovation Centre at DoH, emphasized that this initiative aims to prevent genetic diseases and enhance early intervention. The process includes diagnostics, personalized genetic counseling, and reproductive medicine solutions for at-risk couples.

Genetic disorders that can be prevented through this program include conditions causing vision and hearing loss, blood clotting disorders, developmental delays, organ dysfunction, hormonal imbalances, and seizures. During the pilot phase, over 800 couples in Abu Dhabi were tested, with 86% achieving genetic compatibility. Only 14% required further intervention, highlighting the program's effectiveness in helping couples make informed family planning decisions.